Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Phase Ib/II Results of Akeso's PD-1/CTLA-4 Bispecific Antibody for First-Line Treatment of Advanced Hepatocellular Carcinoma Published at 2023 ESMO 2023-10-24 20:00
OrbiMed Raises $4.3 Billion Across Private Investment Funds 2023-10-24 19:30
Life Molecular Imaging and Sinotau Pharmaceutical Group Announce the Regulatory Approval of their Amyloid PET Imaging Radiopharmaceutical Neuraceq® in China 2023-10-24 16:00
Clinical Trial Application (IND) for BioRay Pharmaceutical's BR105 Injection Receives U.S. FDA Approval 2023-10-24 15:05
Recbio appeared at the 14th China (Taizhou) International Pharmaceutical Fair 2023-10-24 13:39
OBiO Announces Strategic Partnership with Refreshgene to Realize Commercialization of Gene Therapy Product 2023-10-24 12:05
Singapore-based Juniper Biologics Awarded the Most Innovative Oncology Pharmaceutical Company 2023 by GHP Healthcare and Pharmaceutical Awards 2023-10-24 12:00
Cellomics announces Mr. Andy A. Liu as new Group CEO of the Company 2023-10-24 12:00
CCTV+: Jianchangbang Pharmacy: A Thousand Years of Tradition and Excellence 2023-10-24 11:51
Based on recent data presented at 2023 ESMO, the innovative TROP2 ADC SKB264 (MK-2870) shows promising prospects for the treatment of patients with HR+/HER2- metastatic breast cancer who have undergone multiple prior lines of therapy , and its clinical development in other solid tumors is also advancing steadily 2023-10-24 10:19
Wingderm® Has Unveiled the Latest Research of Mesoskin for Mesotherapy Treatment at AMWC 2023-10-24 09:23
Alphamab Oncology updated data from two studies of KN026 in combination with docetaxel for HER2-positive breast cancer at ESMO 2023-10-24 08:41
Alphamab Oncology Announces New Data from Multiple Studies of KN046 with Lung Cancer and Thymic Carcinoma at ESMO 2023-10-24 08:41
LBB Specialties Announces Principal Partnership with Viscofan 2023-10-23 23:00
XINGIMAGING and MITRO BIOTECH CO., LTD. MERGE TO DELIVER FULL-SERVICE CRO OPERATIONS TO GLOBAL RESEARCH INITIATIVES 2023-10-23 22:38
Genesis MedTech initiates enrollment in its North American Early Feasibility Study using the J-Valve™ Transfemoral System for patients with severe aortic regurgitation 2023-10-23 22:00
Transcenta Unveils Updated Efficacy Data from Osemitamab (TST001) Plus CAPOX as First-Line Treatment for G/GEJ Cancer Study at ESMO 2023 2023-10-23 21:48
Certa Therapeutics' FT011 Granted US FDA Orphan Drug Designation for the Treatment of Systemic Sclerosis 2023-10-23 21:30
WAT Medical Donates to the Canadian Red Cross and Peach Arch Hospital 2023-10-23 21:00
AI Diagnostic Platform Company Noul, unveils the result of Malaria study in Ethiopia and Ghana 2023-10-23 21:00
1 134 135 136 137 138 963